Planned Parenthood Affiliate Turns to Botox and IV Drips to Survive After Trump Cuts Federal Funds

Planned Parenthood Mar Monte, the nation’s largest Planned Parenthood affiliate, is facing a financial crisis caused by the Trump administration’s decision to strip federal funding from abortion-rights organizations. To stay afloat, the affiliate is now offering a surprising new line of services: cosmetic treatments such as Botox injections and IV hydration therapy.

Dr. Laura Dalton, Chief Medical Operating Officer for Planned Parenthood Mar Monte, explains the grim reality behind the shift. “There’s uncertainty with HR1,” she says, referring to ongoing legislative battles threatening their funding. “There’s uncertainty about what other actions will be taken that will limit our ability for reimbursement. So there’s that revenue gap that needs to be addressed.”

With around 75% of their patients relying on Medicaid, the loss of federal funding has hit hard. The affiliate has already been forced to close five clinics and can no longer collect Medicaid reimbursements. To compensate, patients now pay out of pocket for the new aesthetic services, creating a crucial cash flow to support the organization’s broader mission.

California lawmakers have allocated $90 million in state funding to Planned Parenthood this year, but it remains unclear if this will be enough to sustain core reproductive health services in the long run. Dr. Dalton emphasizes the need to adapt to patients’ changing needs and preferences, noting that “what our patients want is different than 10, 20, 30 years ago.”

This pivot to cosmetic care is a stark example of how political attacks on abortion access ripple through health services, forcing providers to innovate just to survive. It highlights the ongoing fallout from the Trump administration’s efforts to cripple reproductive rights and underscores the urgent need for sustained support to protect these essential services.